Gilead Sciences signed a contract with four Indian pharmaceutical companies to produce its medication ‘Remdesivir’ which has been found effective in treatment of some COVID-19 patients.
Technical analyst Sudarshan Sukhani has suggested three BUY calls and one SELL call for today’s trading session. Indian markets are expected to open strong for today’s trading session.